Blood test may allow kidney patients to drop most anti-rejection meds
NCT ID NCT04786067
First seen Jan 12, 2026 · Last updated Jun 10, 2026 · Updated 28 times
Summary
This study looked at whether a blood test called AlloSure can identify kidney transplant patients who can safely switch from several anti-rejection drugs to just one, belatacept. 25 adult kidney transplant recipients with stable kidney function were enrolled. The goal was to see if the test could predict who could handle the drug reduction without rejecting their new kidney.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT IMMUNOSUPPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.